Skip to Content

MediciNova Inc MNOV

Morningstar Rating
$1.32 +0.02 (1.54%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MNOV is trading at a 62% discount.
Price
$1.30
Fair Value
$9.46
Uncertainty
Extreme
1-Star Price
$65.89
5-Star Price
$7.37
Economic Moat
Ndns
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MNOV is a good fit for your portfolio.

Trading Information

Previous Close Price
$1.30
Day Range
$1.261.32
52-Week Range
$1.262.66
Bid/Ask
$1.31 / $1.32
Market Cap
$63.86 Mil
Volume/Avg
60,561 / 64,892

Key Statistics

Price/Earnings (Normalized)
Price/Sales
67.68
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
13

Comparables

Valuation

Metric
MNOV
EWTX
IMVT
Price/Earnings (Normalized)
Price/Book Value
1.053.928.07
Price/Sales
67.68
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
MNOV
EWTX
IMVT
Quick Ratio
15.5518.9821.56
Current Ratio
15.6119.5022.14
Interest Coverage
Quick Ratio
MNOV
EWTX
IMVT

Profitability

Metric
MNOV
EWTX
IMVT
Return on Assets (Normalized)
−10.99%−24.36%−43.33%
Return on Equity (Normalized)
−11.59%−25.87%−47.83%
Return on Invested Capital (Normalized)
−13.69%−29.82%−52.69%
Return on Assets
MNOV
EWTX
IMVT
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRSynq$546.8 Bil
VRTX
Vertex Pharmaceuticals IncVqzfx$112.0 Bil
REGN
Regeneron Pharmaceuticals IncXlbnqfc$108.6 Bil
MRNA
Moderna IncWxsz$35.9 Bil
ARGX
argenx SE ADRVfhm$24.1 Bil
BNTX
BioNTech SE ADRJwwx$22.2 Bil
ALNY
Alnylam Pharmaceuticals IncThrhkgj$20.0 Bil
BMRN
Biomarin Pharmaceutical IncFmnccc$17.0 Bil
RPRX
Royalty Pharma PLC Class AKmyvtq$14.0 Bil
INCY
Incyte CorpGrqkts$13.6 Bil

Sponsor Center